Pedro Pablo Pinto G., 2004: Spanish-language review of medical treatment of hydatid disease giving mebendazole at 50-70 mg/kg/day in three divided doses, with the frequency of liver-enzyme rises (10-20%) and the share of patients who had to stop treatment (3.8% in the European series).
Mebendazol : 50-70 mg/kg/día, repartido en tres dosis durante el día
Pedro Pablo Pinto G., 2004: Spanish-language review of medical treatment of hydatid disease giving mebendazole at 50-70 mg/kg/day in three divided doses, with the frequency of liver-enzyme rises (10-20%) and the share of patients who had to stop treatment (3.8% in the European series). Study type: narrative review (articulo de actualizacion), Chile (Universidad Austral de Chile, Valdivia); no patients of its own. Dose recorded: mebendazol 50-70 mg/kg/day in three doses; albendazol 10-15 mg/kg/day in two. Frequency statements: 'Aproximadamente 10-20% de los pacientes desarrollan aumento de las transaminasas…' (about 10-20% of patients develop raised transaminases, mild, self-limited and reversible on stopping) and 'En la serie europea solo un 3.8% de los pacientes debio suspender el tratamiento por anormalidades enzimaticas'. English translation of the quoted excerpt: 'Mebendazole: 50-70 mg/kg/day, divided into three doses during the day.' The quote is the original Spanish as printed, so it is checkable on the page. Funder and conflicts: not stated. This is a secondary review, not a primary study; it is recorded because it is an independent non-English statement of the same high-dose range. Page: article-level HTML, no page numbers (printed pages 57-61).
